THE IMPACT OF OVARIAN LASER-SURGERY ON THE GONADOTROPIN-SECRETION IN WOMEN WITH POLYCYSTIC OVARIAN DISEASE

被引:57
作者
ROSSMANITH, WG
KECKSTEIN, J
SPATZIER, K
LAURITZEN, C
机构
[1] Department of Obstetrics-Gynecology, University of Ulm, Ulm
关键词
D O I
10.1111/j.1365-2265.1991.tb00298.x
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
To evaluate the effects of ovarian surgery on the deranged episodic gonadotrophin release of women with the polycystic ovarian disease (PCOD), we studied 11 patients with the clinical and endocrinological features of PCOD before and after laparoscopic laser coagulations of ovarian surfaces and cysts. During both occasions, blood was collected at 15-min intervals for 8 h to determine LH and FSH secretory profiles and additionally for 3 h during GnRH injections (25-mu-g twice within 2 h) to assess pituitary responsiveness. Serum testosterone, androstendione and oestrogen (oestrone, oestradiol) levels were markedly reduced (P < 0.05 or less) after surgery. Mean LH concentrations declined (P < 0.001), while FSH levels increased (P < 0.01) following laser treatments. The LH pulse frequencies (by Cluster analysis) did not change after ovarian surgery, but the LH pulse amplitudes were markedly reduced (P < 0.01). Lower (P < 0.05 or less) LH concentrations were attained in response to GnRH challenges, and the stimulated FSH release also tended to decrease after laser treatments. Thus, ovarian surgery in PCOD women resulted in reduced serum sex steroid concentrations and in divergent effects on serum LH and FSH levels. The attenuated pituitary LH responsiveness after ovarian surgery suggests action of sex steroids primarily at the pituitary site, while the increase in FSH concentrations may be attributed to other factors selectively modulating FSH release.
引用
收藏
页码:223 / 230
页数:8
相关论文
共 32 条
[1]   HORMONAL RESPONSE TO ELECTROCAUTERY OF THE OVARY IN PATIENTS WITH POLYCYSTIC OVARIAN DISEASE [J].
AAKVAAG, A ;
GJONNAESS, H .
BRITISH JOURNAL OF OBSTETRICS AND GYNAECOLOGY, 1985, 92 (12) :1258-1264
[2]  
ADASHI EY, 1981, FERTIL STERIL, V36, P320
[3]   CENTRAL OPIOID ACTIVITY IN POLYCYSTIC OVARY SYNDROME WITH AND WITHOUT DOPAMINERGIC MODULATION [J].
BARNES, RB ;
LOBO, RA .
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 1985, 61 (04) :779-782
[4]   PULSATILE LUTEINIZING-HORMONE PATTERNS IN THE FOLLICULAR PHASE OF THE MENSTRUAL-CYCLE, POLYCYSTIC OVARIAN DISEASE (PCOD) AND NON-PCOD SECONDARY AMENORRHEA [J].
BURGER, CW ;
KORSEN, T ;
VANKESSEL, H ;
VANDOP, PA ;
CARON, FJM ;
SCHOEMAKER, J .
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 1985, 61 (06) :1126-1132
[5]   ENHANCED DISPARITY OF GONADOTROPIN-SECRETION BY ESTRONE IN WOMEN WITH POLYCYSTIC OVARIAN DISEASE [J].
CHANG, RJ ;
MANDEL, FP ;
LU, JKH ;
JUDD, HL .
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 1982, 54 (03) :490-494
[6]   EVIDENCE FOR DECREASED ENDOGENOUS DOPAMINE AND OPIOID INHIBITORY INFLUENCES ON LH-SECRETION IN POLYCYSTIC OVARY SYNDROME [J].
CUMMING, DC ;
REID, RL ;
QUIGLEY, ME ;
REBAR, RW ;
YEN, SSC .
CLINICAL ENDOCRINOLOGY, 1984, 20 (06) :643-648
[7]   DOES TESTOSTERONE AFFECT THE NORMAL MENSTRUAL-CYCLE [J].
DEWIS, P ;
NEWMAN, M ;
RATCLIFFE, WA ;
ANDERSON, DC .
CLINICAL ENDOCRINOLOGY, 1986, 24 (05) :515-521
[8]  
DUNAIF A, 1986, J CLIN ENDOCR METAB, V63, P215
[9]   ENDOCRINE EFFECTS OF OVARIAN ELECTROCAUTERY IN PATIENTS WITH POLYCYSTIC OVARIAN DISEASE [J].
GJONNAESS, H ;
NORMAN, N .
BRITISH JOURNAL OF OBSTETRICS AND GYNAECOLOGY, 1987, 94 (08) :779-783
[10]   POLYCYSTIC OVARY .1. CLINICAL AND HISTOLOGIC FEATURES [J].
GOLDZIEHER, JW ;
GREEN, JA .
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 1962, 22 (03) :325-+